SIREN : 832065866
SPINOUEST MEDICAL is a French company founded 8 years ago, specialized in the sector Activités des sièges sociaux. Based in LOIRE-AUTHION (49140), this company of category PME shows in 2019 a revenue of 220 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-25
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2019 |
|---|---|
| Revenue | 220 335 € |
| Net income | 57 251 € |
| EBITDA | 73 775 € |
| Net margin | 26.0% |
In 2019, SPINOUEST MEDICAL achieves revenue of 220 k€. After deducting consumption (0 €), gross margin stands at 220 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 74 k€, representing 33.5% of revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 57 k€, i.e. 26.0% of revenue. This profit can be retained or distributed to shareholders.
220 335 €
220 335 €
73 775 €
72 538 €
57 251 €
33.5%
The debt ratio (= Financial debt / Equity x 100) stands at 29%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 51%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.5 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 26.5% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
29.003%
51.438%
26.545%
0.46
95.9%
In 2019, the debt ratio of SPINOUEST MEDICAL (29.00) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2019, the financial autonomy of SPINOUEST MEDICAL (51.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2019, the repayment capacity of SPINOUEST MEDICAL (0.46) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
The liquidity ratio (= Current assets / Current liabilities) stands at 214.91. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.2x. Danger: operating income does not cover interest charges, unsustainable situation.
214.915
0.228
In 2019, the liquidity ratio of SPINOUEST MEDICAL (214.91) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2019, the interest coverage of SPINOUEST MEDICAL (0.2x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 117 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 36 days. The gap of 81 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 95 days of revenue, i.e. 58 k€ to permanently finance.
58 032 €
117 j
36 j
0 j
95 j
Based on 105 transactions of similar company sales in 2019, the value of SPINOUEST MEDICAL is estimated at 234 907 € (range 67 117€ - 464 221€). With an EBITDA of 73 775€, the sector multiple of 4.5x is applied. The price/revenue ratio is 0.31x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 105 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare SPINOUEST MEDICAL with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sièges sociaux
The revenue of SPINOUEST MEDICAL in 2019 is 220 k€.
Yes, SPINOUEST MEDICAL generated a net profit of 57 k€ in 2019.
The headquarters of SPINOUEST MEDICAL is located in LOIRE-AUTHION (49140), in the department Maine-et-Loire.
The tax return of SPINOUEST MEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
SPINOUEST MEDICAL operates in the sector Activités des sièges sociaux (NAF code 70.10Z). See the 'Sector positioning' section above to compare the company with its competitors.